Author:
Cochrane Elizabeth,Doctor Tahera,Tavella Nicola,Dubois Bethany,McCarthy Lily,Stratis Catherine,Stoffels Guillaume,Bianco Angela,DeBolt Chelsea
Funder
National Center for Advancing Translational Sciences
Reference26 articles.
1. Cell-free DNA screening for trisomies 21, 18, and 13 in pregnancies at low and high risk for aneuploidy with genetic confirmation;Dar;Am J Obstet Gynecol,2022
2. Fetal fraction of cell-free DNA in noninvasive prenatal testing and adverse pregnancy outcomes: a nationwide retrospective cohort study of 56,110 pregnant women;Becking;Am J Obstet Gynecol,2023
3. Screening for fetal chromosomal abnormalities: ACOG practice bulletin, number 226;American College of Obstetricians and Gynecologists (ACOG);Obstet Gynecol,2020
4. First-trimester screening for trisomies by cffDNA testing of maternal blood in singleton and twin pregnancies: Factors affecting test failure;Galeva;Ultrasound Obstet Gynecol,2019
5. Obstetrical, perinatal, and genetic outcomes associated with nonreportable prenatal cell-free DNA screening results;Norton;Am J Obstet Gynecol,2023